Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis

BACKGROUND: Vascular access failure is a huge burden for patients undergoing hemodialysis. Many efforts have been made to maintain vascular access patency, including pharmacotherapy. Angiotensin converting enzyme inhibitor (ACE-I), angiotensin receptor blocker (ARB), and calcium channel blocker (CCB...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fu-An, Chien, Chih-Chiang, Chen, Yu-Wei, Wu, Yu-Te, Lin, Chih-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104366/
https://www.ncbi.nlm.nih.gov/pubmed/27832203
http://dx.doi.org/10.1371/journal.pone.0166362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104366/
https://www.ncbi.nlm.nih.gov/pubmed/27832203
http://dx.doi.org/10.1371/journal.pone.0166362

Ejemplares similares